Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

China flag China · Delayed Price · Currency is CNY
37.39
+0.49 (1.33%)
May 30, 2025, 3:04 PM CST
261.61%
Market Cap 34.36B
Revenue (ttm) 995.20M
Net Income (ttm) -184.03M
Shares Out 919.06M
EPS (ttm) -0.20
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 65,582,436
Average Volume 46,553,627
Open 37.00
Previous Close 36.90
Day's Range 35.21 - 37.73
52-Week Range 8.65 - 37.73
Beta 0.14
RSI 85.66
Earnings Date Aug 29, 2025

About SHE:300255

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 1,254
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300255
Full Company Profile

Financial Performance

In 2024, SHE:300255's revenue was 1.03 billion, a decrease of -26.92% compared to the previous year's 1.41 billion. Losses were -249.48 million, -79.88% less than in 2023.

Financial Statements

News

There is no news available yet.